Literature DB >> 21647801

Seizure and mental status change after surgery for pelvic organ prolapse.

Hindi E Stohl1, Ralph Daher, Frank Aguirre, Chi Chiung Grace Chen.   

Abstract

The syndrome of inappropriate antidiuretic hormone secretion (SIADH) is a well-documented postoperative complication but infrequently seen after gynecologic procedures. Clinical presentation is often insidious, and neurologic sequelae may be severe, especially in women. We report the first published case of postoperative hyponatremia due to SIADH after vaginal reconstructive surgery. Our patient sustained a tonic-clonic seizure on postoperative day 2 in the setting of profound hyponatremia. Early detection and prompt treatment allowed her to achieve a complete recovery. Familiarity with uncommon complications of vaginal surgery is important. Prompt initiation of treatment can prevent potentially fatal consequences.

Entities:  

Mesh:

Year:  2011        PMID: 21647801     DOI: 10.1007/s00192-011-1451-y

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  5 in total

1.  Symptomatic hyponatremia following cesarean section.

Authors:  S Lurie; M Feinstein; Y Mamet
Journal:  J Matern Fetal Neonatal Med       Date:  2002-02

2.  Syndrome of inappropriate antidiuretic hormone after laparoscopic-assisted vaginal hysterectomy.

Authors:  C P Perry
Journal:  J Am Assoc Gynecol Laparosc       Date:  1994-05

3.  Postoperative hyponatremia despite near-isotonic saline infusion: a phenomenon of desalination.

Authors:  A Steele; M Gowrishankar; S Abrahamson; C D Mazer; R D Feldman; M L Halperin
Journal:  Ann Intern Med       Date:  1997-01-01       Impact factor: 25.391

4.  Postoperative hyponatremia. A prospective study.

Authors:  H M Chung; R Kluge; R W Schrier; R J Anderson
Journal:  Arch Intern Med       Date:  1986-02

5.  Postoperative hyponatremic encephalopathy in menstruant women.

Authors:  J C Ayus; J M Wheeler; A I Arieff
Journal:  Ann Intern Med       Date:  1992-12-01       Impact factor: 25.391

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.